Notes: Ciglitazone is an antidiabetic drug of the thiazolidinedione structural class. Ciglitazone is a potent and selective PPARγ ligand. It binds to the PPARγ ligand-binding domain with an EC50 of 3.0 µM.{7575} Ciglitazone is active in vivo as an anti-hyperglycemic agent in the ob/ob mouse model.{7575}